Effect of a cocoa polyphenol extract in spontaneously hypertensive rats

In this study, we evaluated the short-term effect of a cocoa polyphenol extract (CPE), in spontaneously hypertensive rats (SHR). Male 17-22-week-old SHR were administered by intragastric gavage water, 50 mg kg(-1) Captopril or CPE at different doses (13, 26, 80 and 160 mg kg(-1)). The systolic blood pressure (SBP) and diastolic blood pressure (DBP) were recorded by the tail cuff method before the administration and also 2, 4, 6, 8, 24, 48 and 72 h post-administration. Highly significant decreases in the SBP and in the DBP were observed when captopril or CPE was administered to SHR. The cocoa extract produced a dose dependent effect in the SBP of the SHR up to the dose of 80 mg kg(-1). Nevertheless this dose of CPE did not decrease the arterial blood pressure in the normotensive Wistar Kyoto rats. The decrease in the SBP caused by 80 mg kg(-1) of CPE in the SHR (-39.1 ± 3.7 mm Hg) was maximum 6 h post-administration, and the initial values of SBP were recovered 72 h post-administration of this extract. Paradoxically, 160 mg kg(-1) of the cocoa extract caused a decreased antihypertensive effect than lower doses of CPE. In addition, the decrease in DBP was always more accentuated when the dose of CPE administered was lower. Our results suggest that CPE may be used as a functional food ingredient with beneficial effects for controlling arterial blood pressure.     

Antihypertensive Properties of a Pea Protein Hydrolysate during Short‐ and Long‐Term Oral Administration to Spontaneously Hypertensive Rats

This study investigated short‐term (24 h) and long‐term (5 wk) systolic blood pressure (SBP)‐lowering effects in spontaneously hypertensive rats (SHR) of a 5 kDa membrane pea protein hydrolysate permeate (PPH‐5) produced through thermoase hydrolysis of pea protein isolate (PPI). Amino acid analysis showed that the PPH‐5 had lower contents of sulfur‐containing amino acids than the PPI. Size‐exclusion chromatography indicated mainly low molecular weight (<10 kDa) peptides in PPH‐5 but not in the PPI. The PPH‐5 had renin and angiotensin converting enzyme inhibition IC₅₀ values of 0.57 and 0.10 mg/mL (P < 0.05), respectively, and consisted mainly of peptides with 2 to 6 amino acids. Mass spectrometry analysis revealed mainly hydrophilic tetrapeptide sequences. After a single oral administration (100 mg/kg body weight) to SHR, the unheated PPI showed weakest (P < 0.05) SBP‐lowering effect with a –4 mm Hg maximum when compared to –25 mm Hg for heat‐treated PPI and –36 mm Hg for PPH‐5. Incorporation of the PPH‐5 as 0.5% or 1% (w/w) casein substitute in the SHR diet produced maximum SBP reductions of –22 or –26 mm Hg (P < 0.05), respectively after 3 wk. In comparison, the unhydrolyzed PPI produced a maximum SBP reduction of –17 mm Hg also after 3 wk. Potency of the pea products decreased in the 4th and 5th wk, though SBP values of the treated rats were still lower than the untreated control. We conclude that the antihypertensive potency of PPH‐5 may have been due to the presence of easily absorbed hydrophilic peptides.     

Effects of tuber storage protein of yam (Dioscorea alata cv. Tainong No. 1) and its peptic hydrolyzates on spontaneously hypertensive rats

Yam storage protein (YSP) was purified from tubers of Dioscorea alata L. Tainong No. 1 (TN1) to homogeneity by DE‐52 ion‐exchange chromatography. The short‐term (24 h) and long‐term (25 days) antihypertensive effects of YSP‐TN1 and its peptic hydrolyzates (PH‐TN1) were measured in spontaneously hypertensive rats (SHRs). For 24‐h antihypertensive measurements, SHRs (age 10 weeks, body weight from 240 to 250 g) were administered orally once (YSP‐TN1 and PH‐TN1, 40 mg kg^?1 SHR) to measure the mean blood pressure (MBP), systolic blood pressure (SBP) and diastolic blood pressure (DBP). For a long‐term antihypertensive measurement, SHRs (age 12 weeks, body weight from 250 to 270 g) were administered orally once a day for 25 days (YSP‐TN1, 40 mg kg^?1 SHR) to measure SBP, DBP and MBP. Captopril (10 or 15 mg kg^?1 SHR) was used as a positive control. It was found that short‐term administration of 40 mg kg^?1 SHR of YSP‐TN1 and PH‐TN1 effectively lowered SHRs' MBP, SBP and DBP (For YSP‐TN1, the lowest blood pressure was reached in the fourth hour and for PH‐TN1 in the eighth hour). The lasting effects of PH‐TN1 on reduced SHRs' BP were better than those of YSP‐TN1 for one oral administration. For oral administration of 40 mg YSP‐TN1 kg^?1 SHR, the reduced MBP was 21.5 mmHg, which was comparable to 25.2 mmHg (the fourth hour) of 10 mg captopril kg^?1 SHR oral administration. For oral administration of 40 mg PH‐TN1 kg^?1 SHR, the reduced MBP was 33.7 mmHg, comparable to 38.4 mmHg (the fourth hour) of 15 mg captopril kg^?1 SHR. For long‐term 25‐day oral administration of 40 mg YSP‐TN1 kg^?1 SHR once a day, it was found that a feeding trial of YSP‐TN1 effectively lowered SHRs' SBP, DBP and MBP. The greatest reduction in SHRs' blood pressure was reached on the ninth day, for the reduced SBP, 27.7 mmHg; for the reduced DBP, 28.3 mmHg; and for the reduced MBP, 27.5 mmHg. Copyright © 2006 Society of Chemical Industry     

Angiotensin‐I‐Converting Enzyme Inhibitory Activities and In Vivo Antihypertensive Effects of Sardine Protein Hydrolysate

In our previous study, an antihypertensive protein hydrolysate was prepared from sardine. This study aimed to investigate the composition of sardine protein hydrolysate (SPH) and it's in vivo antihypertensive effect. SPH was separated sequentially with ultrafiltration and size exclusion chromatography. Fractions with high angiotensin‐I‐converting enzyme (ACE) inhibitory activity were further analyzed with RP‐HPLC and amino acids analysis. Then, SPH was individually oral administrated to spontaneously hypertensive rats (SHR) and normotensive wistar kyoto rats (WKY) for 4 wk. After treatment, the systolic blood pressure (SBP), organ index, oxidative status, serum ACE activity, and serum angiotensin‐II (ANG‐II) of all the rats were determined. According to the separation and analysis results, 3 main fractions with high ACE‐inhibitory activity were obtained with different amino acids composition. The animal experiments results showed that SPH could significantly reduce SBP (P < 0.05 or P < 0.01) within 4 h after a single oral administration. After a chronic oral administration, a steady state of SBP in SHR rats was attained. The heart weight index and left ventricular weight index were significantly reduced (P < 0.05) in SPH‐treated SHR rats. The malonyldialdehyde (MDA) levels in organs and serum, serum ACE activity, and serum ANG‐II concentration in SPH‐treated SHR rats were significantly lowered (P < 0.05 or P < 0.01) as compared to their controls. Meanwhile there was no significant effect (P > 0.05) on those parameters in WKY rats. These results indicate that SPH can decrease blood pressure in SHR rats and not in WKY rats.     

ACE-inhibitory and antihypertensive properties of a bovine casein hydrolysate

The aim of this study was to investigate the potential angiotensin converting enzyme (ACE)-inhibitory activity and the antihypertensive effect, after a single oral administration, of a pepsin hydrolysed bovine casein (HBC) and a fraction with molecular mass lower than 3000 Da (HBC < 3000). ACE-inhibitory activity was measured by spectrophotometric assay. These products were orally administered by gastric intubation. The systolic (SBP) and the diastolic blood pressure (DBP) were measured in spontaneously hypertensive rats by the tail cuff method before administration and also 2, 4, 6, 8, and 24 h post-administration. HBC showed a potent ACE-inhibitory activity. This activity was 10 times higher in HBC < 3000. HBC and HBC < 3000 decreased the arterial blood pressure of the rats. The decrease in the SBP observed for HBC (400 mg/kg) or HBC < 3000 (200 mg/kg) was less pronounced than that caused by 50 mg/kg of captopril (antihypertensive positive control). However, the maximal decreases in DBP caused by HBC or HBC < 3000 were as high as the maximum decrease observed for captopril. The antihypertensive effect of these products was transient and reverted 24 h after the administration. HBC and HBC < 3000 exert antihypertensive effect caused by small peptides with ACE-inhibitory activity.     

Antihypertensive activity of milk fermented by Enterococcus faecalis strains isolated from raw milk

A total of 231 microorganisms were isolated from raw cow milk samples and the angiotensin-converting enzyme-inhibitory (ACEI) activity of the resultant fermented milk produced with the isolated microorganisms was assayed. Forty-six of these microorganisms were selected on the basis of high ACEI activity. Four Enterococcus faecalis strains stood out as producers of fermented milk with potent ACEI activity (IC₅₀ (the protein concentration that inhibits 50% of ACE activity): 34–59 μg mL⁻¹). Single doses (5 mL kg⁻¹) of the whey fraction obtained from these fermented milk samples were administered to spontaneously hypertensive rats (SHR) and to normotensive Wistar-Kyoto (WKY) rats in order to investigate their possible antihypertensive activity. Highly significant decreases in the systolic blood pressure (SBP) and in the diastolic blood pressure (DBP) were observed when the fermented milk was administered to SHR. Nevertheless, the fermented milk did not modify the SBP and the DBP of the WKY rats. Raw cow milk is an excellent source of wild lactic acid bacteria able to produce fermented milk with antihypertensive activity and antihypertensive activity of milk fermented by Enterococcus faecalis strains was associated with peptides different from Ile-Pro-Pro and Val-Pro-Pro.     

Antihypertensive effect of peptides obtained from Enterococcus faecalis-fermented milk in rats

Previous studies have demonstrated that milk fermented with Enterococcus faecalis decreases the systolic blood pressure (SBP) and the diastolic blood pressure (DBP) of spontaneously hypertensive rats. In this study, we evaluated the antihypertensive activity of the following peptide sequences: LHLPLP, LHLPLPL, LVYPFPGPIPNSLPQNIPP, VLGPVRGPFP, and VRGPFPIIV. These peptides isolated from E. faecalis-fermented milk showed in vitro angiotensin I-converting enzyme-inhibitory activity. Because the most potent angiotensin I-converting enzyme-inhibitory sequences were LHLPLP and LVYPFPGPIPNSLPQ-NIPP, we administered different doses of these peptides to spontaneously hypertensive rats. High doses of the remaining sequences were also administered to these animals. Water served as a negative control and captopril as a positive control. All products were administered orally. The SBP and DBP were measured before administration and also at 2, 4, 6, 8, and 24 h after administration. Before administration of the different products, spontaneously hypertensive rats showed SBP and DBP values of 218 ± 2.5 and 157 ± 5.9 mmHg, respectively (n = 30). The sequences LHLPLP, LVYPF-PGPIPNSLPQNIPP, VLGPVRGPFP, and VRGPFPIIV caused clear and significant decreases in SBP, DBP, or both in the animals. In particular, the antihypertensive effect could be clearly established when 2 or 3 mg/kg of LHLPLP was administered. These 2 doses of LHLPLP showed similar antihypertensive properties. Four hours after administration of captopril or the highest doses of the different peptides, the decreases in the SBP and the DBP (mmHg) were as follows: captopril (SBP = 52 ± 5.8, DBP = 38.8 ± 3.8), 3 mg/kg of LHLPLP (SBP = 25.3 ± 8.2, DBP = 29.5 ± 7.6), 6 mg/kg of LVYPFPGPIP-NSLPQNIPP (SBP = 14.9 ± 3.7, DBP = 8.7 ± 4.4), 10 mg/kg of LHLPLPL (SBP = 7.7 ± 4.1, DBP = 9.4 ± 3.1), 10 mg/kg of VLGPVRGPFP (SBP = 16.2 ± 5.8, DBP = 21.64 ± 3.2), and 10 mg/kg of VRGPFPIIV (SBP = 16.05 ± 2.74, DBP = 9.19 ± 3.49). The results obtained suggest that the sequences LHLPLP, LVYPFPGPIPNSLPQ-NIPP, VLGPVRGPFP, and VRGPFPIIV could be responsible, at least in part, for the antihypertensive properties described for E. faecalis-fermented milk.     

含血管紧张素转化酶抑制肽的酪蛋白水解物与紫薯提取物联用对原发性高血压大鼠血压的影响

以富含血管紧张素转化酶（angiotensin converting enzyme,ACE）抑制肽的酪蛋白水解物和富含花青素的紫薯提取物为原料,灌胃12 周龄雄性原发性高血压大鼠（spontaneously hypertensive rats,SHR）和正常雄性Wistar大鼠,研究富含ACE抑制肽的酪蛋白水解物和紫薯提取物对SHR血压的影响。用不同剂量的酪蛋白水解物（10、20、30、40 mg/kg,以体质量计,下同）和紫薯提取物（5.4、10.8、21.6、32.4 mg/kg,花青素含量为9.25%）分别灌胃SHR和Wistar大鼠。然后选用酪蛋白水解物的2 个剂量组分别与紫薯提取物的3 个剂量组联合灌胃SHR。用智能无创血压计测量SHR血压变化。结果表明：富含ACE抑制肽的酪蛋白水解物和富含花青素的紫薯提取物,在实验灌胃剂量范围内均具有较好的降压效果,而且两者联用进行单次灌胃后降压效果显著提高（P＜0.05）。其中酪蛋白水解物（10 mg/kg）分别与紫薯提取物3 个剂量（5.4、10.8、21.6 mg/kg）联合灌胃SHR后4 h或者5 h,血压分别降低了（24.67±4.46）、（28.47±3.96）、（41.51±4.89） mmHg。用酪蛋白水解物（20 mg/kg）分别与紫薯提取物的3 个剂量（5.4、10.8、21.6 mg/kg）联合灌胃SHR后5 h或者6 h,SHR血压分别降低了（38.03±3.46）、（43.92±2.92）、（47.20±4.31） mmHg。两者联用灌胃后对Wistar正常大鼠的血压无影响。另外,酪蛋白水解物2 个剂量（10、20 mg/kg）和紫薯提取物（10.8 mg/kg）分别联合使用,间隔4 h灌胃1 次,每天灌胃2 次,SHR大鼠血压较灌胃前分别降低了（28.20±3.02）、（43.54±2.55） mmHg,而且能较长时间维持在较低血压水平。因此,富含ACE抑制肽的酪蛋白水解物和富含花青素的紫薯提取物联合食用对SHR的降压具有显著效果。     

花生肽对原发性高血压大鼠的降压作用

研究花生肽对原发性高血压大鼠（SHR）的降压作用。采用鼠尾体外间接血压测量方法,观察花生肽单次给药和连续给药对SHR大鼠血压的影响。单次给药后,花生肽组可以降低SHR大鼠的血压;连续给药14d,花生肽组可以稳定降低SHR大鼠的血压并维持在较稳定的水平。单次或连续给药花生肽均对SHR大鼠具有降低血压的效果。     

Hypotensive effect of a sweetpotato protein digest in spontaneously hypertensive rats and purification of angiotensin I-converting enzyme inhibitory peptides

We have investigated angiotensin I-converting enzyme (ACE) inhibitory activity in an enzyme digest of sweetpotato protein, the antihypertensive effect of the digest in spontaneously hypertensive rats (SHR), and the identification of an ACE inhibitory peptide. Protein was prepared from squeezed juice of sweetpotato by isoelectric focusing precipitation. Three kinds of proteases were selected for effective protein digestion. The digest, sweetpotato peptide (SPP), exhibited strong ACE inhibitory activity (IC₅₀: 18.2 μg/ml). SPP was orally administered by gavage to SHR at a dose of 100 mg/kg or 500 mg/kg. The systolic blood pressure and the diastolic blood pressure were measured at 0 (before administration), 2, 4, 8, and 24 h after administration. A dose-dependent decrease in systolic blood pressure in SHR was observed after oral administration of SPP. Significant differences between SPP-administered rats and control rats were observed 4 and 8 h after administration in the 500 mg/kg-administered group and 8 h after administration in the 100 mg/kg-administered group. Diastolic blood pressure also decreased in the SPP-administered groups, although the difference between SPP-administered rats and control rats was not significant. These results suggest that SPP may be useful in the prevention or treatment of hypertension. Peptides with ACE inhibitory activity were purified from SPP by absorption chromatography and preparative HPLC using an ODS column. The amino acid sequences of isolated peptides were I-T-P, I-I-P, G-Q-Y and S-T-Y-Q-T; their ACE inhibitory activities (IC₅₀) were 9.5 μM, 80.8 μM, 52.3 μM and 300.4 μM, respectively. In conclusion, I-T-P is a novel, strong ACE inhibitory peptide.     

Absorption-enhancing Treatments for Antihypertensive Activity of Oligopeptides from Tuna Cooking Juice: In Vivo Evaluation in Spontaneously Hypertensive Rats

ABSTRACT The aim of this study was to evaluate the absorption‐enhancing effect for antihypertensive activity of an angiotensin I‐converting enzyme (ACE) inhibitory oligopeptides in spontaneously hypertensive rats (SHR). The oligopeptides OA3, derived from tuna cooking juice, significantly reduced systolic blood pressure (SBP) in SHR at the doses of 0.5, 0.75, and 1.0 g/kg body weight; their efficacies were exhibited in a dose‐dependent manner. Emulsification, microencapsulation, and lipophilization were applied to enhance the antihyperten‐sive activity of OA3 at the dose of 0.5 g/kg body weight in SHR individually. Lipophilization revealed most effectively by 16 mm Hg in SBP in SHR 4 h after oral administration; the significant different effect lasted more than 6 h. Such efficacy is greater than that from no further treated OA3 with the dose of 1.0 g/kg body weight. Enhancing treatments by using 30% gum Arabic and 30% lecithin exhibited minor effects by 13 and 11 mm Hg, respectively. Results imply that these additional treatments could further enhance and extend the antihyperten‐sive effect of OA3 oligopeptides. This suggests that absorption‐enhancing treatments improve the bioavailability of oligopeptides to exhibit higher antihypertensive effect. Furthermore, these enhancing effects may be brought about by the changes in cell membrane permeation or the protection of oligopeptides.     

鮰鱼皮明胶ACE抑制肽降血压活性的研究

鮰鱼皮为斑点叉尾鮰鱼片加工的主要副产物,利用鮰鱼皮明胶制备降血压肽(ACE抑制肽)可为鮰鱼皮的高值化利用提供参考。本文通过对原发性高血压大鼠(SHR)进行一次性及长期给药(28 d)实验,研究鮰鱼皮明胶ACE抑制肽(Mr3000 Da)的降血压作用,并测定大鼠血清和肺组织中的ACE活性和Ang II含量。实验结果表明:一次性给药和长期灌胃给药鮰鱼皮明胶ACE抑制肽均对SHR大鼠有显著降血压作用,降血压效果呈剂量依赖性;高剂量组SHR大鼠灌胃给药2 h后,其收缩压由206 mmHg降至159 mmHg;高剂量组SHR大鼠经长期灌胃给药10 d后,血压一直保持在155 mmHg左右;同时,鮰鱼皮明胶ACE抑制肽对正常血压大鼠的降血压作用不显著。鮰鱼皮明胶ACE抑制肽对SHR大鼠血清和肺组织中的ACE活性有显著的抑制作用,从而使大鼠血清和肺组织中Ang II含量显著降低,而对正常血压的SD大鼠的血清和肺组织中ACE活性和Ang II含量影响不显著。     

Goldenberry (Physalis peruviana) Juice Rich in Health‐Beneficial Compounds Suppresses High‐Cholesterol Diet‐Induced Hypercholesterolemia in Rats

Goldenberries (Physalis peruviana) are a promising exotic fruit that could be a subject of many novel foods. No reports are available on the effect of administration of goldenberries on different aspects of blood profile in experimental animals. The objective of this study was to investigate the effect of feeding goldenberry juice on hypercholesterolemia by analyzing the changes in the blood profile of high‐cholesterol diet (HCD)‐fed rats. The chemical composition and antiradical properties of juice were determined. Generally, rats fed with goldenberry juice showed lower levels of total cholesterol, total triacylglycerol and total low‐density lipoprotein cholesterol, as well as higher levels of high‐density lipoprotein cholesterol in comparison with animals fed with HCD and cholesterol‐free diet. Juice administration induced a decrease in the activity of glutamic pyruvic transaminase compared with the positive control group after 2 months of administration. There was a remarkable decrease in total serum protein, albumin and globulin for groups treated with goldenberry juice. Histological examination of the liver and kidney were also conducted. The results demonstrated that consumption of goldenberry juice may provide beneficial effects on reversing HCD‐associated detrimental changes.     

Angiotensin-converting enzyme activity in plasma and tissues of spontaneously hypertensive rats after the short- and long-term intake of hydrolysed egg white

This paper evaluates the effects of the short- (1 g/kg) and long-term (0.5 and 1 g/kg/day) oral intake of egg white hydrolysed with pepsin (hEW) and the long-term oral intake (1 g/kg/day) of egg white (EW) on local angiotensin-converting enzyme (ACE) activities in plasma and other tissues of spontaneously hypertensive rats (SHR), as compared to the effect of the ACE inhibitor prototype captopril. The rats treated with hEW were classed in a different group than the control rats and the rats treated with EW by cluster analysis, taking into account their tissue ACE activities and their systolic blood pressure (SBP). Principal component analysis (PCA) showed that SBP in SHR was negatively related with ACE activity in plasma and positively related with ACE activity in aorta and kidney. ACE activity in plasma significantly increased after the long-term treatment with hEW (0.5 g/kg/day). ACE activity in aorta and kidney was significantly inhibited 4 h after the short-term administration of hEW. The long-term treatment with hEW caused local effects on ACE activity in aorta, kidney and lungs that followed a pattern similar, but less pronounced, than that caused by captopril.     

HYPOTENSIVE ACTIVITY OF MUSCLE PROTEIN AND GLUTEN HYDROLYSATES OBTAINED BY PROTEASE TREATMENT

Protein hydrolysates obtained by treatment with papain, trypsin, chymotrypsin and actinase all exhibited inhibitory activity (IC50: 3.4–41.8 mg%) toward angiotensin‐converting enzyme (ACE) (EC 3.4.15.1). In particular, the protein hydrolysate obtained by treatment with papain showed the highest inhibitory activity (3.7–5.3 mg%). The ACE inhibitory activity of the gluten hydrolysate obtained with actinase was mainly due to peptides of less than 500 Da in molecular mass. On the other hand, the ACE inhibitory activity of the myofibrillar protein hydrolysate obtained with papain was due to peptides of both less and more than 500 Da in molecular mass. The blood pressure of spontaneously hypertensive rats (SHR) administered the myofibrillar protein hydrolysate was significantly reduced at 2 h after administration. The blood pressure of SHR was also reduced at 2 h after administration of the gluten hydrolysate, and this effect continued until 6 h. These hydrolysates may potentially be useful as antihypertensive food materials.     

Vascular effects and antihypertensive properties of κ-casein macropeptide

The blood-pressure-lowering effect of bovine κ-casein macropeptide (CMP), previously reported to exhibit a modest angiotensin-converting enzyme (ACE)-inhibitory activity in vitro, was evaluated in spontaneously hypertensive rats (SHR). The oral administration of CMP (150 mg kg⁻¹) significantly reduced the systolic blood pressure (SBP) of SHR. The antihypertensive action was more pronounced when CMP was treated with trypsin. The sequence MAIPPKK, identified in the tryptic hydrolysate of bovine CMP, significantly reduced blood pressure at a dose of 10 mg kg⁻¹. The CMP and its tryptic peptides induced relaxation of endothelium-intact aortic rings. The sequence MAIPPKK also evoked a significant relaxation effect; however, the shorter sequence MAIPPK and the strong ACE-inhibitory tripeptide IPP exhibited a vascular relaxing effect lower than 10%. The implications of vascular relaxing mechanisms, as well as the possibility that the tripeptide IPP is at least partially responsible for the antihypertensive effects of CMP, are discussed.     

Feeding trial of instant food containing lyophilised yam powder in hypertensive subjects

BACKGROUND: It was reported in a previous paper that the yam tuber storage protein dioscorin exhibited antihypertensive effects on spontaneously hypertensive rats. The aim of the present study was to evaluate and compare the effects of packets of instant food (30 g) with (treated meal) and without (placebo) lyophilised yam powder on hypertensive subjects. RESULTS: A placebo‐controlled feeding trial was conducted daily for 5 weeks (stage 1), followed by a 1 week washout and then a 5 week crossover (stage 2). Twenty‐one subjects finished the trial. One packet of treated meal contained 140 ± 2.54 mg of dioscorin according to enzyme‐linked immunosorbent assay. The blood pressure results of the treated meal and placebo groups at stage 1 end versus originals, but not at stage 2 end versus stage 2 beginning, were significantly different by the paired t test. Systolic (SBP) and diastolic (DBP) blood pressure readings after treated meal intervention, but not after placebo intervention, differed significantly from the original values based on one‐way analysis of variance followed by the post hoc Tukey test; the reductions in SBP and DBP were 6.52 and 4.76 mmHg respectively. The feeding trial did not appear to affect serum lipid profiles or other biochemical measurements of cardiovascular risk. CONCLUSION: Intake of an instant food containing 140 mg of dioscorin over 5 weeks had a regulating effect on human blood pressure. Copyright © 2008 Society of Chemical Industry     

动物与临床试验——评价大豆低聚肽的降血压效果

为了检验大豆低聚肽的降血压效果,首先进行了动物试验,选择SHR(自发性高血压)大鼠30只,其中21只为雌性大鼠,9只为雄性大鼠。喂养方法:大豆低聚肽加入饮水中服用,并辅以乳粉;对照组仅给乳粉和饮水。实验期间,每天下午测定血压(SBP)。结果表明,大豆低聚肽的降血压作用很明显。服药3d后,实验组的血压与对照组的血压相比低30mmHg。剂量对降血压效应也有影响。低剂量能使血压下降到较低的值,但是随后效应有反弹;高剂量则可较早地降低血压,并且在较长的时间内保持平衡。临床实验研究按照中国高血压指南标准选择原发性高血压患者40例,平均年龄为51.66±11.35岁,分别在服用大豆低聚肽前和1个月后测定血压、心率,记录心电图等和血液中相关生化指标。研究认为,服用大豆低聚肽可能会降低原发性高血压患者的血压,其机制可能与其对血压紧张素转化酶(Angiotensinconvertingenzyme,ACE)的抑制有关。     

ANTIHYPERTENSIVE CAPACITY OF DEFATTED SOFT-SHELLED TURTLE POWDER AFTER HYDROLYSIS BY GASTROINTESTINAL ENZYMES

Soft‐shelled turtle (SST) is a high‐value animal cultivated in Asia, possessing many mystical folk curative properties in traditional Chinese medicine. This study investigated the effects of enzymatic hydrolysate derived from defatted SST powder on inhibition of angiotensin I‐converting enzyme (ACE) activity and on antihypertensive effect of spontaneously hypertension rats (SHR). The SST powder showed limited inhibition of ACE (IC₅₀ = 16.7 mg/mL), while its enzymatic hydrolysate exhibited a fivefold increase in inhibition of ACE (IC₅₀ = 3.2 mg/mL). The fraction of molecular weight (Mr) less than 1000 Da obtained through ultrafiltration exhibited the best inhibition of ACE (IC₅₀ = 2.8 mg/mL). The fraction of Mr less than 1000 was then separated into six fractions by gel filtration, eluted with deionized water, and the ACE inhibitory activity from three fractions was analyzed. Fractions 4 and 5 with Mr at 560–600 Da and 440–480 Da had the strongest inhibition on ACE. Single oral administration of 500 mg/kg BW dose from enzymatic hydrolysates to SHR showed a noticeable decrease of systolic blood pressure (SBP) at the sixth and eighth hour after the administration when compared to 0 h (P < 0.05). The fractions with Mr over 5000 Da from enzymatic hydrolysate significantly lowered SBP after a single oral administration at a dose of 500 mg/kg BW in SHR. On the other hand, Mr less than 5000 and 1000 Da significantly lowered SBP after a single oral administration at a dose of 150 and 50 mg/kg BW. The results suggested that hydrolysates of defatted SST powder, produced with a gastrointestinal enzyme, showed inhibition of ACE activity and antihypertensive effect in SHR.